Artron was founded in Burnaby, British Columbia, Canada in 2002 by a team of talented and experienced professionals and scientists. The company has two divisions that caters to different segments of IVD industry; namely Artron Bioreseach, Inc. & Artron Laboratories, Inc. Artron Laboratories, Inc. manufactures and markets high quality rapid lateral flow tests for the detection of fertility hormones, tumor markers, drugs ofabuse, cardiac markers, infectious diseases, food safety, genetically modified organisms, and pet diseases. Artron's research and development facility in Burnaby, Canada is fully equipped with advanced technology for operating in the fields of Molecular Biology, Monoclonal Antibody Development, Protein Purification and Rapid Test Kit Development.Artron BioResearch Inc. with state-of-art R&D and manufacture facilities, is well known for developing and manufacturing, in a large-scale, a great array of high quality antibodies, antigens and critical components of RDT products for direct application in lateral flow tests (LFT) (fertility hormones, tumor markers, drugs of abuse, cardiac markers, infectious diseases, genetically modified organisms, etc), as well as other applications (chemiluminescence test, ELISA and research-based immunoassays).In addition, Artron offers the most advanced and cost-effective customized research and development services to design, develop, integrate, and validate all aspects of RDT systems.As a world class leader in the rapid diagnostic test industry, we are dedicated to bringing innovations into the development of protein-based LFT for diagnosis and analyte detection.Artron is an ISO 9001; 2011 & ISO 13485: 2008 certified company and it is committed to helping building up the best innovative clinical diagnostics tests across the world.